Featured news in The Life Sciences Report



ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
Today's Research Reports on IntelliPharmaCeutics International, Centric Health, ProMIS Neurosciences and Theratechnologies (9/14/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
The Zacks Analyst Blog Highlights: Illumina, Celgene , Athersys and Achillion (9/14/2018)

view
 


Cesca Therapeutics Inc. (KOOL:NASDAQ)
Cesca Therapeutics' Chief Executive Officer, Chris Xu, To Be The Keynote Speaker At The Cell Therapy World Asia 2018 Conference On September 20, 2018 (9/13/2018)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
ProMIS Neurosciences Appoints James Kupiec, MD as Chief Medical Officer (9/13/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
Celgene (CELG) Stock Sinks As Market Gains: What You Should Know (9/12/2018)

view
 

Celgene Corp. (CELG:NASDAQ)
IPOs and Foreign Investment Propel Biotech: 4 Top Picks (9/13/2018)

view
 

Celgene Corp. (CELG:NASDAQ)
Zacks.com featured highlights include: Nucor, PCM, Celgene and Rayonier (9/13/2018)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Granted New U.S. Patent for Industrial Scale Manufacturing of NurOwn® (9/13/2018)

view
 


Caladrius Biosciences Inc. (CLBS:NASDAQ)
Is Caladrius Biosciences (CLBS) Stock Outpacing Its Medical Peers This Year? (9/12/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
Boost Your Portfolio With These 4 High Earnings Yield Stocks (9/12/2018)

view
 

Celgene Corp. (CELG:NASDAQ)
Endocyte Announces FDA's Acceptance of Trial Endpoint Change (9/11/2018)

view
 

Celgene Corp. (CELG:NASDAQ)
Immuno Oncology & Targeted Therapy Companies Set to Breakout (9/12/2018)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm to Present at FDA and Scientific Workshops Highlighting Innovation in ALS Trial Designs and Continued Progress with NurOwn® Cellular Therapy Platform (9/12/2018)

view